Milk Allergy Clinical Trial
Official title:
The Effectiveness of Milk Allergy Elimination Through NAET Treatments
We sought to determine the efficacy of NAET® in permanently eliminating milk allergy for a
sample of patients.
We hypothesize that the subjects in the experimental group will show similar level of
allergies and sensitivities initially on all nine diagnostic measures used here. After
receiving the NAET treatments, the Experimental group will demonstrate a significant
reduction in the milk sensitivities and allergies when compared to the control group at the
final evaluation using same diagnostic measures.
Background: Although several standard clinical techniques are used to detect and treat
common allergic conditions, each one is limited in scope and requires to follow repeated
treatment protocols. The non-invasive system known as NAET® does not generally have such
limitations and has over the last twenty-three years been demonstrated to be effective
clinically in thousands of cases. NAET® is a natural treatment that utilizes standard
medical diagnostic measures along with kinesiolgocal, chiropractic and oriental testing,
procedures to identify the allergens, as well as the intensity of reactions to the allergens
which vary from individual to individual. Treatment consists of a sequence of spinal
manipulations at specific thoracic and lumbar spinal levels along with acupuncture
acupressure on configurations of standard acupuncture points.
Methods: In a double blind study, 26 patients with diagnosed milk allergy (13 males, 13
females, age range between 18-65 years) were randomly assigned to 2 groups:
1. NAET®/Experimental group, and
2. Placebo/control group The study was conducted by 12 volunteer-clinicians from NAET
Research associates, divided into six investigator groups. Each group conducted a
designated sequential part of the study independently from all other groups, that is,
was blinded from all other groups for the duration of the study. Subjects from both
groups (Experimental and Control) were evaluated immediatedly before treatment and
eight weeks thereafter using the following nine diagnostic measures: Subjective history
(Allergy Symptom Rating Scale or ASRS); ALCAT Test; antibodies to milk protein in the
blood serum by Immunoglobulins G, Immunoglobulins A, Immuno-globulins M, and
Immunoglobulins E (IgG, IgA, IgM, IgE) by Elisa method (enzyme linked Immunozorbant
Assay); Intradermal testing for milk sensitivity. NSTRS (Kinesiological muscle response
testing also known as Neuromuscular Sensitivity Testing) and Pulse difference Rating
Scale (PDRS) were tested by two well trained NST clinicians at two different times
before and after the treatments. Both groups demonstrated allergic sensitivities to
whole milk test sample in varying degrees. After completing the evaluations, the
Experimental group received 2 NAET® treatments on whole milk, on two consecutive
Saturdays. The Placebo group received two treatments on placebo samples on the same
days along with the experimental group on two consecutive Saturdays as well. At the end
of the treatment phase, once again both groups were evaluated for whole milk test
sample using all of the nine diagnostic measures.
Results On the nine diagnostic measures there was a significant difference in the means of
the before and after measures of the Experimental group, while they remained almost the same
for the Placebo group. At 95% CI, p-values were less than 0.05 in all tests except for IgG
study (p-value=1.30). NSTRS and PDRS were evaluated by two clinicians at different time to
evaluate the intertester relability among two clinicians for these two tests. A significant
correlation was noticed with the results both testers received on these two testing–NST and
PDRS (p-value <0.0001).
Conclusion The study demonstrated the efficacy of eliminating or reducing milk allergy using
the NAET® treatment protocol. This study also evaluated the reliability of performing two
testing procedures (NST & PDRS) by two independent examiners in testing the subjects for
milk at two different times. There was a significant correlation in the results they
received as shown above, when the two clinicians tested the subjects independently,
demonstrating that there is a good reliability between these well trained clinicians in
their performance while doing these two evaluations.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01950533 -
The Utility of Food-Specific IgE Measured With the IMMULITE 2000 Assay to Predict Symptomatic Food Allergy
|
||
Completed |
NCT02579876 -
Milk Patch for Eosinophilic Esophagitis
|
Phase 2 | |
Completed |
NCT04318483 -
Characteristic and Evolution of an Atypical IgE-mediated Cow Milk Allergy Form With Hands and Feet Angio-oedema
|
||
Completed |
NCT02317952 -
Formula for Children With Cow's Milk Allergy
|
N/A | |
Completed |
NCT00968110 -
Xolair Treatment for Milk Allergic Children
|
Early Phase 1 | |
Recruiting |
NCT03309488 -
Basophil Activation Test to Diagnose Food Allergy
|
||
Recruiting |
NCT05309772 -
The Clinical Impact of the Basophil Activation Test to Diagnose Food Allergy
|
N/A | |
Terminated |
NCT02719405 -
Impact of Infant Formula on Resolution of Cow's Milk Allergy
|
Phase 2 | |
Completed |
NCT01361347 -
Safety of Oral Immunotherapy for Cow's Milk Allergy in School-aged Children
|
Phase 4 | |
Completed |
NCT01157117 -
OIT and Xolair® (Omalizumab) in Cow's Milk Allergy
|
Phase 2 | |
Active, not recruiting |
NCT00732654 -
The Safety and Efficacy of Sublingual/Oral Immunotherapy for the Treatment of Milk Protein Allergy
|
Phase 1/Phase 2 | |
Recruiting |
NCT03819556 -
Swedish Study of Immunotherapy for Milk Allergy in Children
|
N/A |